Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Naltrexone as a Treatment for Self-Injurious Behavior

NCT02726035 is registered in ClinicalTrials.gov with Western Michigan University School of Medicine as lead sponsor.

NCT NCT02726035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02726035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Naltrexone as a Treatment for Self-Injurious Behavior
Lead sponsor
Western Michigan University School of Medicine
Phase
Phase 4
Overall status
Withdrawn
Start date
February 22, 2014
Completion date
January 4, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

self mutilation, self-injurious behavior